The Prophylaxis of Herpes Group Infections in Patients with Haematological Malignancy

Haematological malignancy provides a model of acquired combined immunodeficiency. During intensive treatment the degree to which the patient is immunocompromised (IC) is increased and is comparable to that seen in the Acquired Immunodeficiency Syndrome (AIDS). Fortunately the patient with a haematological malignancy usually has a limited period of compromised immunity unlike the AIDS patient.